GlaxoSmithKline Marks Three Billionth Tablet Donation to Fight LF; DuPont Nutrition and Health Joins Up with AvidBiotics for New Technologies; Boehringer Ingelheim Launches Online Pharma Game - Health Minute for September 28, 2012

Primary tabs

GlaxoSmithKline Marks Three Billionth Tablet Donation to Fight LF; DuPont Nutrition and Health Joins Up with AvidBiotics for New Technologies; Boehringer Ingelheim Launches Online Pharma Game - Health Minute for September 28, 2012

tweet me:
.@GSK Marks 3 Bil LF Tablet Donation; DuPont Nutrition & Health Partners w/ AvidBiotics; @boehringerus's Online Game http://3bl.me/rhnw34

Multimedia from this Release

Friday, September 28, 2012 - 11:10am

CONTENT: Press Release

GlaxoSmithKline has donated its three billionth albendazole tablet to fight lymphatic filariasis, LF, and intestinal worm infections. Since the start of the program in 1998, over 500 million people have been treated for LF.

DuPont Nutrition and Health has announced a strategic collaboration with AvidBiotics to develop new bactericidal protein technologies. Through the agreement, DuPont will gain exclusive rights to the technololgies for food and food protection systems. AvidBiotics antibacterial technology is based on R-type bacteriocins which recognize target bacteria, then disrupt the organism to kill it.

German drug maker Boehringer Ingelheim has launched a social networking game, Syrum, to promote science and innovation in the digital community. The game, developed over two years but a team of researchers, futurists, and branding experts, allows players to build and run their own pharmaceutical company, and is the industry’s first social game.

For more information on these and other stories, go to 3blmedia.com

Video Source: GlaxoSmithKline Marks Three Billionth Tablet Donation to Fight LF; DuPont Nutrition and Health Joins Up with AvidBiotics for New Technologies; Boehringer Ingelheim Launches Online Pharma Game 

Keywords: 3bl Media | AvidBiotics | Boehringer Ingelheim | DuPont Nutrition and Health | GlaxoSmithKline | Health | Innovation | Pharmaceutical | Syrum | bactericidal protein technologies | food protection systems

CONTENT: Press Release

parse.ly